Islay Capital Management LLC purchased a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 2,123 shares of the company’s stock, valued at approximately $129,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC bought a new position in shares of Prestige Consumer Healthcare in the 4th quarter worth $26,000. Banque Cantonale Vaudoise raised its position in shares of Prestige Consumer Healthcare by 40.9% in the 3rd quarter. Banque Cantonale Vaudoise now owns 1,075 shares of the company’s stock worth $60,000 after acquiring an additional 312 shares in the last quarter. PNC Financial Services Group Inc. raised its position in shares of Prestige Consumer Healthcare by 29.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 3,293 shares of the company’s stock worth $184,000 after acquiring an additional 754 shares in the last quarter. Advisor Group Holdings Inc. raised its position in shares of Prestige Consumer Healthcare by 15.5% in the 4th quarter. Advisor Group Holdings Inc. now owns 3,331 shares of the company’s stock worth $203,000 after acquiring an additional 448 shares in the last quarter. Finally, Advisor Partners LLC acquired a new position in Prestige Consumer Healthcare during the 4th quarter valued at about $209,000.
Separately, StockNews.com began coverage on shares of Prestige Consumer Healthcare in a report on Thursday, March 31st. They set a “buy” rating on the stock.
Prestige Consumer Healthcare (NYSE:PBH – Get Rating) last announced its earnings results on Thursday, February 3rd. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.10. Prestige Consumer Healthcare had a return on equity of 13.90% and a net margin of 17.85%. The firm had revenue of $274.40 million for the quarter, compared to analyst estimates of $260.39 million. During the same quarter last year, the firm posted $0.81 EPS. The business’s revenue was up 14.9% on a year-over-year basis. On average, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.04 earnings per share for the current fiscal year.
Prestige Consumer Healthcare Company Profile (Get Rating)
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
- Get a free copy of the StockNews.com research report on Prestige Consumer Healthcare (PBH)
- Hasbro Insider Bets Big On Stock Rebound
- Schwab Stock Can Be Caught Down Here
- Snap Up Some Snap-On On Post-Earnings Weakness
- Time to Buy any Dip in Prologis Stock
- 3 Resilient Stocks to Buy for Retirement
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.